HomepageMedicineBioNTech and Autolus Announce Strategic Alliance to Bolster CAR-T Cell Pipeline Medicine BioNTech and Autolus Announce Strategic Alliance to Bolster CAR-T Cell Pipeline admin Posted on February 10, 2024 BioNTech will invest $200 million and get access to Autolus’ manufacturing sites. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostHow My Cat Helped Me Find Love: Dr. Karyn’s Valentine Next PostA ‘Mother’ Is Mourned by the Queer New Yorkers She Left Behind You Might Also Like Medicine Pharma Pulse 1/24/25: Clinical Technology Advancements, Encourage Patient Accountability & more admin January 26, 2025 Medicine IQVIA Responds to FTC’s Block on Acquisition of Propel Media admin January 6, 2024 Medicine Measuring the ROI of Marketing Efforts admin October 21, 2024 Medicine Pharma Pulse 2/4/25: Analyzing Supply Chain Complexities, Navigating Medicare Advantage in 2025 & more admin February 4, 2025
Medicine Pharma Pulse 1/24/25: Clinical Technology Advancements, Encourage Patient Accountability & more admin January 26, 2025
Medicine Pharma Pulse 2/4/25: Analyzing Supply Chain Complexities, Navigating Medicare Advantage in 2025 & more admin February 4, 2025